Plasma-lyte 148: Clinical Trials

3 trials of Plasma-lyte 148, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Terminated 1, Unknown 1

Follow Plasma-lyte 148: new trials by email Literature Review of Plasma-lyte 148 trials Research Report on Plasma-lyte 148

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Goal-directed Fluid Therapy During Deep Inferior Epigastric Perforator (DIEP) Free Flap Breast Reconstruction
Plasma-lyte (static group), Norepinephrine (static group), Plasma-lyte (dynamic group) - Hypotension During Surgery
Phase 4TerminatedAlgemeen Ziekenhuis Maria Middelares412023-11-232026-10-28
Plasma-Lyte 148® versUs Saline Study
Plasma-Lyte 148®, 0.9% sodium chloride - Hypovolemia
Phase 4CompletedThe George Institute50372017-09-012023-08-08
0,9% NaCl Effect on Kidney Function and Glycocalyx in Patients Operated on for Primary Hiparthrosis
Plasma-lyte, 0,9% saline - Nephrotoxicity
Phase 4UnknownRegional Hospital Holstebro402015-03-012015-08-19

Conditions studied

Critical Illness (1)  ·  Hypotension (1)  ·  Hypovolemia (1)

Sponsors

Algemeen Ziekenhuis Maria Middelares (1)  ·  Regional Hospital Holstebro (1)  ·  The George Institute (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Denmark (1)  ·  New Zealand (1)

Top investigators

Erling B Perdersen, MD, DMSc (1)  ·  Jesper N Bech, MD, PhD (1)  ·  Silvie Allaert, MD (1)  ·  Simon Finfer, Professor (1)

Results publications

PMID 33771116, PMID 35041780